NCT00865176View on ClinicalTrials.gov

Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Hypertension
Interventions
DRUG

Eplerenone 50 mg Tablets Sandoz Inc., USA

DRUG

Inspra 50 mg Tablets GD Searle LLC, USA

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY